Cannabis use frequency and pain interference among people with HIV

被引:3
作者
Klepp, T. D. [1 ]
Heeren, T. C. [2 ]
Winter, M. R. [3 ]
Lloyd-Travaglini, C. A. [3 ]
Magane, K. M. [4 ]
Romero-Rodriguez, E. [5 ]
Kim, T. W. [1 ,6 ]
Walley, A. Y. [1 ,6 ]
Mason, T. [4 ]
Saitz, R. [1 ,4 ,6 ]
机构
[1] Boston Univ, Dept Med, Clin Addict Res & Educ CARE Unit, Sch Med,Sect Gen Internal Med, Boston, MA 02215 USA
[2] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
[3] Boston Univ, Biostat & Epidemiol Data Analyt Ctr, Sch Publ Hlth, Boston, MA USA
[4] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA USA
[5] Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIB, Cordoba, Spain
[6] Boston Med Ctr, Grayken Ctr Addict, Boston, MA 02118 USA
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2023年 / 35卷 / 08期
关键词
HIV; AIDS; pain; cannabis; marijuana; opioid; VALIDATION; MEDIATION; SEVERITY;
D O I
10.1080/09540121.2023.2208321
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Cannabis is often used by people with HIV (PWH) for pain, yet study results are inconsistent regarding whether and how it affects pain. This study examines whether greater cannabis use frequency is associated with lower pain interference and whether cannabis use modifies the association of pain severity and pain interference among 134 PWH with substance dependence or a lifetime history of injection drug use. Multi-variable linear regression models examined the association between past 30-day cannabis use frequency and pain interference. Additional models evaluated whether cannabis use modified the association between pain severity and pain interference. Cannabis use frequency was not significantly associated with pain interference. However, in a model with interaction between cannabis use frequency and pain severity, greater cannabis use frequency attenuated the strength of the association between pain severity and pain interference (p = 0.049). The adjusted mean difference (AMD) in pain interference was +1.13, + 0.81, and +0.05 points for each 1-point increase in pain severity for those with no cannabis use, 15 days of use, and daily use, respectively. These findings suggest that attenuating the impact of pain severity on pain-related functional impairment is a potential mechanism for a beneficial role of cannabis for PWH.
引用
收藏
页码:1235 / 1242
页数:8
相关论文
共 32 条
[1]   Cannabis in painful HIV-associated sensory neuropathy - A randomized placebo-controlled trial [J].
Abrams, D. I. ;
Jay, C. A. ;
Shade, S. B. ;
Vizoso, H. ;
Reda, H. ;
Press, S. ;
Kelly, M. E. ;
Rowbotham, M. C. ;
Petersen, K. L. .
NEUROLOGY, 2007, 68 (07) :515-521
[2]   Chronic Pain in HIV [J].
Addis, Dylan R. ;
DeBerry, Jennifer J. ;
Aggarwal, Saurabh .
MOLECULAR PAIN, 2020, 16
[3]  
[Anonymous], 2017, HLTH EFFECTS CANNABI, DOI DOI 10.17226/24625
[4]   Using Confirmatory Factor Analysis to Evaluate Construct Validity of the Brief Pain Inventory (BPI) [J].
Atkinson, Thomas M. ;
Rosenfeld, Barry D. ;
Sit, Laura ;
Mendoza, Tito R. ;
Fruscione, Mike ;
Lavene, Dawn ;
Shaw, Mary ;
Li, Yuelin ;
Hay, Jennifer ;
Cleeland, Charles S. ;
Scher, Howard I. ;
Breitbart, William S. ;
Basch, Ethan .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2011, 41 (03) :558-565
[5]   Cannabis use, pain interference, and prescription opioid receipt among persons with HIV: a target trial emulation study [J].
Becker, William C. ;
Li, Yu ;
Caniglia, Ellen C. ;
Vickers-Smith, Rachel ;
Feinberg, Termeh ;
Marshall, Brandon D. L. ;
Edelman, E. Jennifer .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2022, 34 (04) :469-477
[6]   2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV [J].
Bruce, R. Douglas ;
Merlin, Jessica ;
Lum, Paula J. ;
Ahmed, Ebtesam ;
Alexander, Carla ;
Corbett, Amanda H. ;
Foley, Kathleen ;
Leonard, Kate ;
Treisman, Glenn Jordan ;
Selwyn, Peter .
CLINICAL INFECTIOUS DISEASES, 2017, 65 (10) :E1-E37
[7]   Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study [J].
Campbell, Gabrielle ;
Hall, Wayne D. ;
Peacock, Amy ;
Lintzeris, Nicholas ;
Bruno, Raimondo ;
Larance, Briony ;
Nielsen, Suzanne ;
Cohen, Milton ;
Chan, Gary ;
Mattick, Richard P. ;
Blyth, Fiona ;
Shanahan, Marian ;
Dobbins, Timothy ;
Farrell, Michael ;
Degenhardt, Louisa .
LANCET PUBLIC HEALTH, 2018, 3 (07) :E341-E350
[8]   Validation of a brief measure of anxiety-related severity and impairment: The Overall Anxiety Severity and Impairment Scale (OASIS) [J].
Campbell-Sills, Laura ;
Norman, Sonya B. ;
Craske, Michelle G. ;
Sullivan, Greer ;
Lang, Ariel J. ;
Chavira, Denise A. ;
Bystritsky, Alexander ;
Sherbourne, Cathy ;
Roy-Byrne, Peter ;
Stein, Murray B. .
JOURNAL OF AFFECTIVE DISORDERS, 2009, 112 (1-3) :92-101
[9]   Cannabidivarin for HIV-Associated Neuropathic Pain: A Randomized, Blinded, Controlled Clinical Trial [J].
Eibach, Luca ;
Scheffel, Simone ;
Cardebring, Madeleine ;
Lettau, Marie ;
Celik, M. Ozgur ;
Morguet, Andreas ;
Roehle, Robert ;
Stein, Christoph .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (04) :1055-1062
[10]   Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial [J].
Ellis, Ronald J. ;
Toperoff, Will ;
Vaida, Florin ;
van den Brande, Geoffrey ;
Gonzales, James ;
Gouaux, Ben ;
Bentley, Heather ;
Atkinson, J. Hampton .
NEUROPSYCHOPHARMACOLOGY, 2009, 34 (03) :672-680